Diagnosis

Concerning AI-generated data showing the low attendance of women at breast screenings has been published in the US. Data suggests that 53.3 per cent of commercially insured women received their recommended screening mammogram between 2022 and 2023. This is up from 47.3 per cent in the prior two-year period, an increase of nearly 13 per [...]

Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalised care.  Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, finding over 3,000 harmful genetic changes [...]

New research has shown that an artificial intelligence (AI)-enabled digital stethoscope helped doctors identify twice as many cases of heart failure compared to a control group that received usual obstetric care and screening.  Heart failure during pregnancy is a dangerous and often under-detected condition because common symptoms – shortness of breath, extreme fatigue and trouble [...]

A new study has has found that women who received a false-positive result that required additional imaging or biopsy were less likely to return for that follow-up screening. Early detection of breast cancer through mammography screening continues to save lives. However, abnormal findings on mammograms can lead to women being recalled for additional imaging and [...]

A new study has found that a blood test measuring three independent biological markers can better predict risk of major cardiovascular events over the next three decades than measuring only one. In a landmark study of 27,939 initially healthy American women, a single measure of high-sensitivity C-reactive protein (hsCRP, a marker of vascular inflammation), low [...]

The technology could help doctors find malignancies in mammograms, freeing up clinical time

Singaporean startup FathomX raised US$2M funding to develop its AI model for mammograms. FanthomX aims to increase the accuracy of mammograms in breast cancer detection using AI-integrated devices for detection, prevention and diagnostics.  Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images [...]

A new partnership aims to advance AI-enabled digital pathology for end-to-end breast tumour profiling PathPresenter, a digital pathology platform and 4D Path, a Boston company producing computer-aided cancer diagnostic products, are announcing a global partnership to distribute 4D Q-plasia OncoReader Breast within the new clinical workflow platform, ClinPx. The 4D Q-plasia OncoReader Breast uses digitised [...]

FemTech World speaks to Petronela Sandulache of CorDiFio about why heart condition diagnoses are harder for women